Science Explorer Back to mapMap
Discussion
Researcher · Institut Claudius Regaud · France

Ben Allal

Ben Allal publishes mostly in Oncology, Molecular Biology and Genetics, on topics such as HER2/EGFR in Cancer Research, Chronic Lymphocytic Leukemia Research and Lymphoma Diagnosis and Treatment.

ORCID 0000-0002-4207-2219 OpenAlex
World rank
#4,838,305
of 7,710,434 ranked researchers
Rank in France
#203,898
of 324,115
Works
45
Citations
667
Citations per work
14.8
h-index
15
i10-index 18Top 36% in Oncology
Ben Allal

What does Ben Allal research?

Ben Allal's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (14%).

Health Sciences: 20 works · 44.6% of their workMedicine: 20 works · 44.6% of their workOncology: 7 works · 15.2% of their workGenetics: 4 works · 8.1% of their workPathology and Forensic Medicine: 4 works · 8.1% of their workPulmonary and Respiratory Medicine: 3 works · 7.1% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 6.1% of their workEverything else: 19 works · 41.3% of their workLife Sciences: 6 works · 14.1% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 14.1% of their workMolecular Biology: 6 works · 14.1% of their workTHEIR WORKBen Allal45works
Life Sciences14%Health Sciences45%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2044.6%
  2. Everything else1941.3%
    1. Biochemistry, Genetics and Molecular Biology614.1%
  1. 1Oncology15% of their works
  2. 2Molecular Biology14% of their works
  3. 3Genetics8% of their works
  4. 4Pathology and Forensic Medicine8% of their works
  5. 5Pulmonary and Respiratory Medicine7% of their works
  6. 6Radiology, Nuclear Medicine and Imaging6% of their works

Research topics

Which keywords describe Ben Allal's research?

The keywords of their largest research topics: Chemotherapy, Rituximab, Breast Cancer, HER2, Trastuzumab, Chronic Lymphocytic Leukemia, Genomic Aberrations and Classification.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Chemotherapy142 topics
  2. Rituximab132 topics
  3. Breast Cancer122 topics
  4. HER291 topic
  5. Trastuzumab91 topic
  6. Chronic Lymphocytic Leukemia71 topic
  7. Genomic Aberrations71 topic
  8. Classification61 topic
  9. Lymphoma61 topic
  10. Signaling62 topics
  11. Human Papillomavirus51 topic
  12. Oropharyngeal Cancer51 topic
  13. BCR-ABL41 topic
  14. EGFR Mutations41 topic
  15. Imatinib41 topic
  16. Targeted Therapy41 topic
  17. Estrogen31 topic
  18. PI3K/AKT pathway31 topic
  19. Receptor31 topic
  20. mTOR31 topic

Where does Ben Allal work?

Ben Allal's main affiliation in the publication record is Institut Claudius Regaud, France.

How many publications and citations does Ben Allal have?

OpenAlex counts 45 works and 667 citations for Ben Allal, an h-index of 15, ranking #4,838,305 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ben Allal. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.